No Prescription

Alpha Index Z

No Prescription » Products » Alpha Index Z

List of Drugs:

A  B  C  D  E  F  G  H  I  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Z  #

Products Z:

ZAART H Hyzaar

Zanaflex (Tizanidine)

Zantac Generic Ranitidine

Zantac (Ranitidine)

Zarontin Generic Ethosuximide

Zarontin Syrup Generic Ethosuximide

Zebeta (Bisoprolol)

Zeffix Generic Imaivudine

Zelnorm (Tegaserod)

Zerit (Stavudine)

Zero Nicotine

Zestoretic (Lisinopril + Hydrochlorothiazide)

Zestril (Lisinopril)

Zestril Prinivil

Zetia (Ezetimibe)

ZIDOVIR 300 AZT

ZIDOVIR AZT

Ziprax Suprax

Zipsydon Geodon

Zithromax Generic Azithromycin

Zithromax (Azithromycin)

Zitrotek Zithromax

ZOBID D Voltaren

Zocon Diflucan

Zocor

Zocor Forte Lipex

Zocor (Simcard)

ZOFLUT Generic Fluticasone

Zofran Generic Ondansetron

Zofran (Ondansetron)

Zoladex Generic Goserelin

Zoloft Lustral

Zomig Generic Zolmitriptan

ZONISEP Zonegran

Zoton Prevacid

Zovirax Generic Aciclovir

Zovirax (Acyclovir)

Zovirax Ophtalmic Pomade Generic Aciclovir

Zovirax Pump Pack Cream for Herpes Generic Aciclovir

Zurig Uloric

Zyban (Bupropion)

Zyban Wellbutrin

Zycolchin Colchicum

Zyloprim (Allopurinol)

ZYLORIC Lopurin

Zymar Eye Drops Generic Gatifloxacin

Zynicor Ikorel

ZYRTEC Generic Cetirizine

Zyrtec (Cetirizine)

Previous 

No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.